Breaking News

Phlow to Expand CDMO Services and Open New Lab

The new lab will aid clients in reducing production costs, decreasing development times, and lowering environmental impact.

On December 12th, 2022, Phlow Corp. will expand its CDMO services and open its new laboratory co-located in Richmond, VA at the Advanced Pharmaceutical Development Center alongside its industry-leading partner, United States Pharmacopeia (USP).
 
The opening of the laboratories marks Phlow’s expansion into the commercial sector, offering their manufacturing and development expertise to top pharmaceutical and biotechnology companies. The laboratories provide customized R&D services for small molecule active pharmaceutical ingredients (APIs) and key starting materials (KSMs).
 
Leveraging the resources and R&D expertise of USP and Phlow, the lab will aid clients in reducing production costs, decreasing development times, and lowering environmental impact all while improving cost efficiency and time to market.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters